These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 35513235)

  • 1. Mortality Outcomes by Fibrosis Stage in Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-analysis.
    Ng CH; Lim WH; Hui Lim GE; Hao Tan DJ; Syn N; Muthiah MD; Huang DQ; Loomba R
    Clin Gastroenterol Hepatol; 2023 Apr; 21(4):931-939.e5. PubMed ID: 35513235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association Between Fibrosis Stage and Outcomes of Patients With Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis.
    Taylor RS; Taylor RJ; Bayliss S; Hagström H; Nasr P; Schattenberg JM; Ishigami M; Toyoda H; Wai-Sun Wong V; Peleg N; Shlomai A; Sebastiani G; Seko Y; Bhala N; Younossi ZM; Anstee QM; McPherson S; Newsome PN
    Gastroenterology; 2020 May; 158(6):1611-1625.e12. PubMed ID: 32027911
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease.
    Angulo P; Kleiner DE; Dam-Larsen S; Adams LA; Bjornsson ES; Charatcharoenwitthaya P; Mills PR; Keach JC; Lafferty HD; Stahler A; Haflidadottir S; Bendtsen F
    Gastroenterology; 2015 Aug; 149(2):389-97.e10. PubMed ID: 25935633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fibrosis progression in nonalcoholic fatty liver vs nonalcoholic steatohepatitis: a systematic review and meta-analysis of paired-biopsy studies.
    Singh S; Allen AM; Wang Z; Prokop LJ; Murad MH; Loomba R
    Clin Gastroenterol Hepatol; 2015 Apr; 13(4):643-54.e1-9; quiz e39-40. PubMed ID: 24768810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: Systematic review and meta-analysis.
    Dulai PS; Singh S; Patel J; Soni M; Prokop LJ; Younossi Z; Sebastiani G; Ekstedt M; Hagstrom H; Nasr P; Stal P; Wong VW; Kechagias S; Hultcrantz R; Loomba R
    Hepatology; 2017 May; 65(5):1557-1565. PubMed ID: 28130788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up.
    Ekstedt M; Hagström H; Nasr P; Fredrikson M; Stål P; Kechagias S; Hultcrantz R
    Hepatology; 2015 May; 61(5):1547-54. PubMed ID: 25125077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Magnetic Resonance vs Transient Elastography Analysis of Patients With Nonalcoholic Fatty Liver Disease: A Systematic Review and Pooled Analysis of Individual Participants.
    Hsu C; Caussy C; Imajo K; Chen J; Singh S; Kaulback K; Le MD; Hooker J; Tu X; Bettencourt R; Yin M; Sirlin CB; Ehman RL; Nakajima A; Loomba R
    Clin Gastroenterol Hepatol; 2019 Mar; 17(4):630-637.e8. PubMed ID: 29908362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence and Characteristics of Nonalcoholic Fatty Liver Disease and Fibrosis in People Living With HIV Monoinfection: A Systematic Review and Meta-analysis.
    Kalligeros M; Vassilopoulos A; Shehadeh F; Vassilopoulos S; Lazaridou I; Mylonakis E; Promrat K; Wands JR
    Clin Gastroenterol Hepatol; 2023 Jul; 21(7):1708-1722. PubMed ID: 36642292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lean non-alcoholic fatty liver disease and the risk of all-cause mortality: An updated meta-analysis.
    Wongtrakul W; Charatcharoenwitthaya N; Charatcharoenwitthaya P
    Ann Hepatol; 2024; 29(3):101288. PubMed ID: 38278181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Meta-analysis on Associated Risk of Mortality in Nonalcoholic Fatty Liver Disease.
    Fu CE; Ng CH; Yong JN; Chan KE; Xiao J; Nah B; Bong SHS; Win KM; Bwa AH; Lim WH; Tan DJH; Zeng RW; Chew N; Teng MLP; Siddiqui MS; Oben JA; Sanyal AJ; Wong VW; Noureddin M; Muthiah M
    Endocr Pract; 2023 Jan; 29(1):33-39. PubMed ID: 36273685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of a Simulation Model to Estimate Long-term Outcomes in Patients with Nonalcoholic Fatty Liver Disease.
    Chhatwal J; Dalgic OO; Chen W; Samur S; Bethea ED; Xiao J; Hur C; Corey KE; Loomba R
    JAMA Netw Open; 2022 Sep; 5(9):e2230426. PubMed ID: 36098969
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Performance of non-invasive tests and histology for the prediction of clinical outcomes in patients with non-alcoholic fatty liver disease: an individual participant data meta-analysis.
    Mózes FE; Lee JA; Vali Y; Alzoubi O; Staufer K; Trauner M; Paternostro R; Stauber RE; Holleboom AG; van Dijk AM; Mak AL; Boursier J; de Saint Loup M; Shima T; Bugianesi E; Gaia S; Armandi A; Shalimar ; Lupșor-Platon M; Wong VW; Li G; Wong GL; Cobbold J; Karlas T; Wiegand J; Sebastiani G; Tsochatzis E; Liguori A; Yoneda M; Nakajima A; Hagström H; Akbari C; Hirooka M; Chan WK; Mahadeva S; Rajaram R; Zheng MH; George J; Eslam M; Petta S; Pennisi G; Viganò M; Ridolfo S; Aithal GP; Palaniyappan N; Lee DH; Ekstedt M; Nasr P; Cassinotto C; de Lédinghen V; Berzigotti A; Mendoza YP; Noureddin M; Truong E; Fournier-Poizat C; Geier A; Martic M; Tuthill T; Anstee QM; Harrison SA; Bossuyt PM; Pavlides M;
    Lancet Gastroenterol Hepatol; 2023 Aug; 8(8):704-713. PubMed ID: 37290471
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liver fibrosis scores and prognosis in patients with cardiovascular diseases: A systematic review and meta-analysis.
    Yan Z; Liu Y; Li W; Zhao X; Lin W; Zhang J; Yu S; Ma J; Wang J; Yu P; Li W; Liu X
    Eur J Clin Invest; 2022 Nov; 52(11):e13855. PubMed ID: 36001034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Women Have a Lower Risk of Nonalcoholic Fatty Liver Disease but a Higher Risk of Progression vs Men: A Systematic Review and Meta-analysis.
    Balakrishnan M; Patel P; Dunn-Valadez S; Dao C; Khan V; Ali H; El-Serag L; Hernaez R; Sisson A; Thrift AP; Liu Y; El-Serag HB; Kanwal F
    Clin Gastroenterol Hepatol; 2021 Jan; 19(1):61-71.e15. PubMed ID: 32360810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibrosis Severity as a Determinant of Cause-Specific Mortality in Patients With Advanced Nonalcoholic Fatty Liver Disease: A Multi-National Cohort Study.
    Vilar-Gomez E; Calzadilla-Bertot L; Wai-Sun Wong V; Castellanos M; Aller-de la Fuente R; Metwally M; Eslam M; Gonzalez-Fabian L; Alvarez-Quiñones Sanz M; Conde-Martin AF; De Boer B; McLeod D; Hung Chan AW; Chalasani N; George J; Adams LA; Romero-Gomez M
    Gastroenterology; 2018 Aug; 155(2):443-457.e17. PubMed ID: 29733831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatocellular carcinoma in patients with nonalcoholic fatty liver disease: A systematic review and meta-analysis: HCC and Steatosis or Steatohepatitis.
    Petrelli F; Manara M; Colombo S; De Santi G; Ghidini M; Mariani M; Iaculli A; Rausa E; Rampulla V; Arru M; Viti M; Lonati V; Ghidini A; Luciani A; Facciorusso A
    Neoplasia; 2022 Aug; 30():100809. PubMed ID: 35636146
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fibrosis stage but not NASH predicts mortality and time to development of severe liver disease in biopsy-proven NAFLD.
    Hagström H; Nasr P; Ekstedt M; Hammar U; Stål P; Hultcrantz R; Kechagias S
    J Hepatol; 2017 Dec; 67(6):1265-1273. PubMed ID: 28803953
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Racial and Ethnic Disparities in Nonalcoholic Fatty Liver Disease Prevalence, Severity, and Outcomes in the United States: A Systematic Review and Meta-analysis.
    Rich NE; Oji S; Mufti AR; Browning JD; Parikh ND; Odewole M; Mayo H; Singal AG
    Clin Gastroenterol Hepatol; 2018 Feb; 16(2):198-210.e2. PubMed ID: 28970148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes of Nonalcoholic Steatohepatitis After Liver Transplantation: An Updated Meta-Analysis and Systematic Review.
    Yong JN; Lim WH; Ng CH; Tan DJH; Xiao J; Tay PWL; Lin SY; Syn N; Chew N; Nah B; Dan YY; Huang DQ; Tan EXX; Sanyal AJ; Noureddin M; Siddiqui MS; Muthiah MD
    Clin Gastroenterol Hepatol; 2023 Jan; 21(1):45-54.e6. PubMed ID: 34801743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The utility of NAFLD fibrosis score for prediction of mortality among patients with nonalcoholic fatty liver disease: A systematic review and meta-analysis of cohort study.
    Jaruvongvanich V; Wijarnpreecha K; Ungprasert P
    Clin Res Hepatol Gastroenterol; 2017 Dec; 41(6):629-634. PubMed ID: 28716600
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.